EQUITY RESEARCH MEMO

Pacific Science

Generated 5/9/2026

Executive Summary

Conviction (model self-assessment)65/100

Pacific Science (est. 1963) is a privately held US leader in temperature-controlled laboratory equipment and integrated cold chain services, headquartered in Seattle. The company provides end-to-end solutions for preserving biological, clinical, and pharmaceutical materials, including cryogenic storage, ultra-low freezers, stability chambers, and monitoring systems. Serving as a single-source provider, Pacific Science supports the life sciences industry from equipment sale and installation to ongoing maintenance, ensuring regulatory compliance and sample integrity. With over six decades of experience, the company has built a reputation for reliability and technical expertise, positioning it as a trusted partner for biopharma, diagnostics, and research institutions. Looking ahead, Pacific Science is well-positioned to benefit from the expanding biopharmaceutical sector and increasing demand for cold chain logistics driven by cell and gene therapies, mRNA vaccines, and biologics. The company's private status allows for strategic flexibility, though it limits public disclosure of growth metrics. Key opportunities include expanding its service footprint in emerging biotech hubs and upgrading its product line with IoT-enabled monitoring solutions. While no major catalysts are immediately visible, the company's steady market presence suggests consistent organic growth.

Upcoming Catalysts (preview)

  • TBDExpansion into East Coast Biotech Hubs60% success
  • TBDLaunch of Next-Generation IoT Monitoring System70% success
  • TBDStrategic Partnership with a Major Biopharma Company50% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)